Literature DB >> 3182827

The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance.

T C White1, F Fase-Fowler, H van Luenen, J Calafat, P Borst.   

Abstract

We have induced drug resistance against methotrexate, an inhibitor of dihydrofolate reductase, and CB3717, an inhibitor of thymidylate synthetase in a strain of Leishmania tarentolae. The drug-resistant strains contain extrachromosomal DNA circles of 68 kilobases with a 30-kilobase inverted duplication flanked by 4- and 5 kilobase unique segments. We show that these circles are highly homologous to the drug-induced H circles of L. tropica (1). All three L. tarentolae strains analyzed contain a chromosomal copy of the H region without duplication, but two of the three strains contain extrachromosomal H circles as well, predominantly present as H circle dimers in one strain and as tetramers in the other. After induction of methotrexate resistance, monomeric circles, presumably derived from the oligomers, become the major type of circle. Our results indicate that the H region represents a genomic region that can be copied at very low frequency to yield circles by a precise, but unusual mechanism under natural conditions in wild-type cells. Although superficially analogous to the episomes of bacteria, the system is without precedent in nature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Inverted repeats as genetic elements for promoting DNA inverted duplication: implications in gene amplification.

Authors:  C T Lin; W H Lin; Y L Lyu; J Whang-Peng
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

2.  A cruciform-dumbbell model for inverted dimer formation mediated by inverted repeats.

Authors:  C T Lin; Y L Lyu; L F Liu
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae.

Authors:  C Kündig; A Haimeur; D Légaré; B Papadopoulou; M Ouellette
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

Review 4.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

5.  Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae.

Authors:  K Grondin; C Kündig; G Roy; M Ouellette
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

6.  Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.

Authors:  J Bestman-Smith; I Schmit; B Papadopoulou; G Boivin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 7.  DNA repair pathways in trypanosomatids: from DNA repair to drug resistance.

Authors:  Marie-Michelle Genois; Eric R Paquet; Marie-Claude N Laffitte; Ranjan Maity; Amélie Rodrigue; Marc Ouellette; Jean-Yves Masson
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

8.  Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania.

Authors:  R Mukhopadhyay; S Dey; N Xu; D Gage; J Lightbody; M Ouellette; B P Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Multidrug resistance in Leishmania donovani is conferred by amplification of a gene homologous to the mammalian mdr1 gene.

Authors:  D M Henderson; C D Sifri; M Rodgers; D F Wirth; N Hendrickson; B Ullman
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

10.  Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania.

Authors:  K Grondin; B Papadopoulou; M Ouellette
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.